Circulating and disseminated tumor cells in pancreatic cancer and their role in patient prognosis: a systematic review and meta-analysis | Zendy

David D. Stephenson | Zendy; Christopher B. Nahm | Zendy; Terence C. Chua | Zendy; Anthony J. Gill | Zendy; Anubhav Mittal | Zendy; Philip de Reuver | Zendy; Jaswinder S. Samra | Zendy

Open Access

Circulating and disseminated tumor cells in pancreatic cancer and their role in patient prognosis: a systematic review and meta-analysis

Author(s) -

David D. Stephenson,

Christopher B. Nahm,

Terence C. Chua,

Anthony J. Gill,

Anubhav Mittal,

Philip de Reuver,

Jaswinder S. Samra

Publication year - 2017

Publication title -

oncotarget

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.373

H-Index - 127

ISSN - 1949-2553

DOI - 10.18632/oncotarget.19928

Subject(s) - medicine , circulating tumor cell , pancreatic cancer , hazard ratio , meta analysis , oncology , bone marrow , cancer , subgroup analysis , confidence interval , pathology , metastasis

Disseminated tumor cells (DTCs) and circulating tumor cells (CTCs) have been postulated to seed metastases and contribute to poorer patient outcomes in many types of solid cancer. To date, no systematic reviews have examined the role of both DTCs and CTCs in pancreatic cancer. We aimed to determine the prognostic value of DTCs/CTCs in pancreatic cancer using a systematic review and meta-analysis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research